Compound file

CJC-1295 (no DAC) / Ipamorelin Protocol

A dual-peptide protocol combining CJC-1295 without DAC (short half-life 30 min–2 hours) and Ipamorelin to produce pulsatile GH release mimicking natural physiology. Individual peptides have limited human data; combination protocols lack peer-reviewed clinical validation. Proposed benefits include enhanced recovery, muscle synthesis, and metabolic health, but direct clinical evidence for the synergistic combination is absent.